Johnson & Johnson (JNJ) Dividends Paid - Common (2009 - 2026)
Johnson & Johnson's (JNJ) quarterly Dividends Paid - Common came in at $3.1 billion in Q1 2026, up 4.75% year-on-year from $3.0 billion in Q1 2025, and little changed quarter-over-quarter from $3.1 billion in Q4 2025.
Johnson & Johnson (JNJ) Dividends Paid - Common (2009 - 2026) Analysis & Trends
Johnson & Johnson has disclosed Dividends Paid - Common across 18 years of filings, most recently posting $3.1 billion for Q1 2026.
- Dividends Paid - Common for Q1 2026 came in at $3.1 billion, up 4.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.5 billion (up 4.86% YoY), and the FY2025 annual result was $12.4 billion, up 4.72% from the prior year.
- Dividends Paid - Common came in at $3.1 billion for Q1 2026 at Johnson & Johnson, roughly flat from $3.1 billion in the prior quarter.
- In the past five years, Dividends Paid - Common ranged from a high of $3.4 billion in Q1 2023 to a low of $2.8 billion in Q2 2022.
- The 5-year median for Dividends Paid - Common is $3.0 billion (2024), against an average of $3.0 billion.
- Peak annual rise in Dividends Paid - Common reached 5.56% in 2023, while the deepest fall reached 16.74% in 2023.
- Johnson & Johnson's Dividends Paid - Common stood at $2.8 billion in 2022, then advanced by 2.8% to $2.9 billion in 2023, then gained by 4.15% to $3.0 billion in 2024, then rose by 4.93% to $3.1 billion in 2025, then changed by 0.0% to $3.1 billion in 2026.
- The last three Dividends Paid - Common figures came in at $3.1 billion (Q1 2026), $3.1 billion (Q4 2025), and $3.1 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 96,436,181.12 Bn | 96,436,176.16 Bn | 7.76 Bn | -866.88 Mn |
| 2 | Eli Lilly | 1,017.30 Bn | 1,012.01 Bn | 16.22 Bn | 1.55 Bn |
| 3 | Johnson & Johnson | 579.61 Bn | 557.55 Bn | 15.96 Bn | 3.13 Bn |
| 4 | AbbVie | 402.30 Bn | 392.96 Bn | 10.78 Bn | 3.09 Bn |
| 5 | Merck | 294.24 Bn | 288.59 Bn | 12.09 Bn | 2.11 Bn |
| 6 | Amgen | 191.82 Bn | 179.78 Bn | 5.87 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn | 1.04 Bn |
| 8 | Pfizer | 149.05 Bn | 136.28 Bn | -1.21 Bn | 2.45 Bn |
| 9 | Bristol Myers Squibb | 116.33 Bn | 105.88 Bn | 8.07 Bn | 1.28 Bn |
| 10 | Novartis Ag | 112.59 Bn | 111.90 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 3.13 Bn |
| Mar 29, 2026 | 3.13 Bn |
| Dec 28, 2025 | 3.13 Bn |
| Dec 28, 2025 | 3.13 Bn |
| Sep 28, 2025 | 3.13 Bn |
| Sep 28, 2025 | 3.13 Bn |
| Jun 29, 2025 | 3.13 Bn |
| Jun 29, 2025 | 3.13 Bn |
| Mar 30, 2025 | 2.99 Bn |
| Mar 30, 2025 | 2.99 Bn |
| Dec 29, 2024 | 2.98 Bn |
| Dec 29, 2024 | 2.98 Bn |
| Sep 29, 2024 | 2.99 Bn |
| Sep 29, 2024 | 2.99 Bn |
| Jun 30, 2024 | 2.99 Bn |
| Jun 30, 2024 | 2.99 Bn |
| Mar 31, 2024 | 2.87 Bn |
| Mar 31, 2024 | 2.87 Bn |
| Dec 31, 2023 | 2.87 Bn |
| Dec 31, 2023 | 2.87 Bn |